255 related articles for article (PubMed ID: 10356275)
1. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.
Quick DJ; Shuler ML
Biotechnol Prog; 1999; 15(3):540-55. PubMed ID: 10356275
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice.
Willems BA; Melnick RL; Kohn MC; Portier CJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):81-91. PubMed ID: 11601884
[TBL] [Abstract][Full Text] [Related]
3. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
Buckpitt A; Chang AM; Weir A; Van Winkle L; Duan X; Philpot R; Plopper C
Mol Pharmacol; 1995 Jan; 47(1):74-81. PubMed ID: 7838135
[TBL] [Abstract][Full Text] [Related]
4. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
Buckpitt AR; Bahnson LS; Franklin RB
J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
[TBL] [Abstract][Full Text] [Related]
5. Combining cell culture analogue reactor designs and PBPK models to probe mechanisms of naphthalene toxicity.
Ghanem A; Shuler ML
Biotechnol Prog; 2000; 16(3):334-45. PubMed ID: 10835232
[TBL] [Abstract][Full Text] [Related]
6. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo.
Buckpitt AR; Warren DL
J Pharmacol Exp Ther; 1983 Apr; 225(1):8-16. PubMed ID: 6834280
[TBL] [Abstract][Full Text] [Related]
7. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
8. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey.
Buckpitt A; Buonarati M; Avey LB; Chang AM; Morin D; Plopper CG
J Pharmacol Exp Ther; 1992 Apr; 261(1):364-72. PubMed ID: 1560380
[TBL] [Abstract][Full Text] [Related]
9. Cellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.
Lakritz J; Chang A; Weir A; Nishio S; Hyde D; Philpot R; Buckpitt A; Plopper C
J Pharmacol Exp Ther; 1996 Sep; 278(3):1408-18. PubMed ID: 8819528
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells.
Chichester CH; Buckpitt AR; Chang A; Plopper CG
Mol Pharmacol; 1994 Apr; 45(4):664-72. PubMed ID: 8183245
[TBL] [Abstract][Full Text] [Related]
12. A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: formation of 2-hydroxyethyl adducts with hemoglobin and DNA.
Csanády GA; Denk B; Pütz C; Kreuzer PE; Kessler W; Baur C; Gargas ML; Filser JG
Toxicol Appl Pharmacol; 2000 May; 165(1):1-26. PubMed ID: 10814549
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
14. A physiologically based pharmacokinetic model for ethylene oxide in mouse, rat, and human.
Fennell TR; Brown CD
Toxicol Appl Pharmacol; 2001 Jun; 173(3):161-75. PubMed ID: 11437638
[TBL] [Abstract][Full Text] [Related]
15. Prevention of naphthalene-induced pulmonary toxicity by glutathione prodrugs: roles for glutathione depletion in adduct formation and cell injury.
Phimister AJ; Nagasawa HT; Buckpitt AR; Plopper CG
J Biochem Mol Toxicol; 2005; 19(1):42-51. PubMed ID: 15736154
[TBL] [Abstract][Full Text] [Related]
16. Covalent interactions of reactive naphthalene metabolites with proteins.
Cho M; Chichester C; Morin D; Plopper C; Buckpitt A
J Pharmacol Exp Ther; 1994 May; 269(2):881-9. PubMed ID: 8182557
[TBL] [Abstract][Full Text] [Related]
17. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
18. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species.
Sweeney RE; Langenberg JP; Maxwell DM
Arch Toxicol; 2006 Nov; 80(11):719-31. PubMed ID: 16718492
[TBL] [Abstract][Full Text] [Related]
19. A preliminary physiologically based pharmacokinetic model for naphthalene and naphthalene oxide in mice and rats.
Sweeney LM; Shuler ML; Quick DJ; Babish JG
Ann Biomed Eng; 1996; 24(2):305-20. PubMed ID: 8678360
[TBL] [Abstract][Full Text] [Related]
20. A physiologically based pharmacokinetic (PB-PK) model for 1,2-dichlorobenzene linked to two possible parameters of toxicity.
Hissink AM; Van Ommen B; Krüse J; Van Bladeren PJ
Toxicol Appl Pharmacol; 1997 Aug; 145(2):301-10. PubMed ID: 9266803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
